NASDAQ:CBIO

Catalyst Biosciences Stock Predictions

> Biotechnology

Invest in CBIO

$13.50

-1.29 (-8.72%)

At Close: Jul 10, 2025

Currently predicting for Mon, 14 Jul 2025

Trading levels for CBIO

Full Access. No Commitment. 14 Days Free!

Long & Short-Term Golden Star Lists

AI Stock Analysis Powered by GPT-4o*

Top 5 Candidates on Every List

Premium Lists

Ad-FREE Browsing

Advanced Stock Screener

GET STARTED!

Already have an account? Sign In Here

Fibonacci Support & Resistance Levels

Level	Price
R3	15.32	13.48%
R2	14.79	9.55%
R1	14.46	7.12%
Price	13.50
S1	13.40	-0.748%
S2	13.07	-3.18%
S3	12.54	-7.11%

Accumulated Volume Support & Resistance Levels

Level	Price
R3	15.87	17.56%
R2	15.55	15.15%
R1	15.09	11.78%
Price	13.50
S1	13.27	-1.70%
S2	0	-
S3	0	-

CBIO Predictions History

1 year ago
PredictionBot.Kathy predicted that CBIO for 2023-08-18 is going $0.464 (-14.37%)

1 year ago
PredictionBot.Warren predicted that CBIO for 2023-08-18 is going $0.470 (-13.29%)

1 year ago
Skagitqg predicted that CBIO for 2023-08-18 is going

2 years ago
JS predicted that CBIO for 2022-08-16 is going $1.93 (2.12%)

2 years ago
JS predicted that CBIO for 2022-07-25 is going $1.75 (-0.57%)

2 years ago
JS predicted that CBIO for 2022-07-21 is going $1.78 (0.56%)

2 years ago
daichi.subac.tdy0520.332323 predicted that CBIO for 2022-07-21 is going

Rank:

6 years ago
NameNotImportant predicted that CBIO for 2019-05-06 is going $8.64 (-1.37%)

6 years ago
NameNotImportant predicted that CBIO for 2019-05-02 is going $8.49 (-1.96%)

6 years ago
NameNotImportant predicted that CBIO for 2019-04-29 is going $8.58 (-4.24%)

ABOUT CATALYST BIOSCIENCES INC

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD);...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RYTM $62.29	42.94%	Jun 25
NOV $12.25	12.33%	Jun 04
G GTM $9.57	8.36%	Jun 02
UAA $5.84	21.23%	May 09
HBM $7.41	45.61%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by